Edmond DE Rothschild Holding S.A. reduced its position in shares of The Allstate Corporation (NYSE:ALL – Free Report) by 4.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 65,278 shares of the insurance provider’s stock after selling 3,000 shares during the period. Edmond DE Rothschild Holding S.A.’s holdings in Allstate were worth $13,141,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Price T Rowe Associates Inc. MD lifted its holdings in shares of Allstate by 25.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 11,709,610 shares of the insurance provider’s stock worth $2,424,710,000 after buying an additional 2,374,684 shares in the last quarter. Boston Partners grew its stake in shares of Allstate by 613.9% in the first quarter. Boston Partners now owns 2,482,654 shares of the insurance provider’s stock valued at $512,627,000 after acquiring an additional 2,134,893 shares in the last quarter. Goldman Sachs Group Inc. increased its position in Allstate by 27.2% during the first quarter. Goldman Sachs Group Inc. now owns 2,328,070 shares of the insurance provider’s stock worth $482,073,000 after acquiring an additional 497,982 shares during the period. Vanguard Group Inc. raised its stake in Allstate by 1.3% in the 2nd quarter. Vanguard Group Inc. now owns 33,235,231 shares of the insurance provider’s stock worth $6,690,584,000 after purchasing an additional 435,145 shares in the last quarter. Finally, Strs Ohio bought a new stake in Allstate in the 1st quarter valued at about $84,408,000. 76.47% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several research analysts have recently commented on the stock. Roth Capital set a $230.00 target price on shares of Allstate and gave the stock a “buy” rating in a report on Friday, September 26th. Morgan Stanley lifted their price objective on Allstate from $235.00 to $245.00 and gave the company an “overweight” rating in a report on Friday, August 1st. Evercore ISI set a $233.00 target price on Allstate and gave the company an “in-line” rating in a research report on Wednesday, October 1st. Keefe, Bruyette & Woods raised their price target on Allstate from $246.00 to $250.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 11th. Finally, BMO Capital Markets upped their price objective on shares of Allstate from $235.00 to $244.00 and gave the stock an “outperform” rating in a research report on Friday, November 7th. Two research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Allstate currently has a consensus rating of “Moderate Buy” and a consensus target price of $237.64.
Insider Buying and Selling
In other Allstate news, insider Suren Gupta sold 21,871 shares of Allstate stock in a transaction that occurred on Friday, November 21st. The stock was sold at an average price of $215.21, for a total value of $4,706,857.91. Following the completion of the sale, the insider directly owned 100,646 shares in the company, valued at approximately $21,660,025.66. The trade was a 17.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders sold a total of 23,671 shares of company stock worth $5,093,974 over the last ninety days. Company insiders own 1.70% of the company’s stock.
Allstate Stock Down 0.8%
ALL stock opened at $212.67 on Tuesday. The firm has a 50-day moving average price of $203.70 and a 200-day moving average price of $202.12. The Allstate Corporation has a 12 month low of $176.00 and a 12 month high of $215.89. The company has a current ratio of 0.43, a quick ratio of 0.43 and a debt-to-equity ratio of 0.37. The stock has a market capitalization of $55.65 billion, a P/E ratio of 10.00, a price-to-earnings-growth ratio of 0.69 and a beta of 0.35.
Allstate (NYSE:ALL – Get Free Report) last announced its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $11.17 EPS for the quarter, beating analysts’ consensus estimates of $5.48 by $5.69. Allstate had a return on equity of 28.74% and a net margin of 8.79%.The company had revenue of $17.26 billion during the quarter, compared to analysts’ expectations of $16.59 billion. During the same period in the prior year, the company earned $3.91 EPS. Allstate’s revenue was up 3.8% compared to the same quarter last year. As a group, equities research analysts anticipate that The Allstate Corporation will post 18.74 EPS for the current fiscal year.
Allstate Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, January 2nd. Shareholders of record on Monday, December 1st will be given a dividend of $1.00 per share. The ex-dividend date of this dividend is Monday, December 1st. This represents a $4.00 dividend on an annualized basis and a yield of 1.9%. Allstate’s dividend payout ratio is 12.95%.
About Allstate
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Recommended Stories
- Five stocks we like better than Allstate
- Golden Cross Stocks: Pattern, Examples and Charts
- D-Wave: Time to Buy the Dip? Or is the Fall Just Starting?
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Hims, Block, and NRG Just Launched Huge Stock Buybacks
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Retail Earnings Roundup: Walmart Scores, Target Slumps in Q3
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
